Ana Sayfa | Dergi Hakkında | Yayın Kurulu | Telif Hakkı Devir Formu | İçindekiler | Arşiv | Yayın Arama | Yazarlara Bilgi | İletişim  
2018, Cilt 48, Sayı 2, Sayfa(lar) 087-099
[ Türkçe Özet ] [ PDF ] [ Benzer Makaleler ]
New Antibacterials
Ahmet Uğur AKBAL1, Ahmet Yılmaz ÇOBAN2, Belma DURUPINAR1
1Ondokuz Mayıs Üniversitesi Tıp Fakültesi, Tıbbi Mikrobiyoloji Anabilim Dalı, Samsun
2Akdeniz Üniversitesi, Sağlık Bilimleri Bilimleri Fakültesi, Antalya
Keywords: Antibacterial, antibiotic, new antibacterials

The increase and spread of antibiotic resistance further increase the risk of infections threatening the individual and the society. New antibiotics active against infections and resistant pathogens are needed. In recent years, new and successful studies in development of new antibacterials have been attracting attention. It has been observed that intensive studies have been carried out in glycopeptides and lipopeptides (oritavancin, telavancin, dalbavancin and surotomycin), oxazolidinones (tedizolid, radezolide, cadazolide and MRX-I), macrolides/ketolides (modithromycin and solitromycin), aminoglycosides (plasomycin), quinolones (nemonoxacin, delafloxacin and avarofloxacin), tetracyclines (omadacycline and eravacycline). In this review, the developments in antibacterials in recent years have been reviewed.

[ Türkçe Özet ] [ PDF ] [ Benzer Makaleler ]
Ana Sayfa | Dergi Hakkında | Yayın Kurulu | Telif Hakkı Devir Formu | İçindekiler | Arşiv | Yayın Arama | Yazarlara Bilgi | İletişim